Presentation TCT 2017 Case #9 (With Discussion): Decision-making During CTO Intervention Presenter: Fernando Alfonso, Nick Curzen, Lei Ge November 01, 2017
Presentation TCT 2017 Rationale and Potential Role for LAA Closure in the PCI and ACS Patient Presenter: Samir R. Kapadia, Ashish Pershad November 01, 2017
Presentation TCT 2017 Case #7 (With Discussion): Decision-making During LMCA Intervention Presenter: Fernando Alfonso, Nick Curzen, Erick Schampaert November 01, 2017
Presentation TCT 2017 The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status Presenter: Deepak L. Bhatt, C. Michael Gibson, Pascal Vranckx November 01, 2017
Presentation TCT 2017 The AUGUSTUS Trial: Apixaban in Patients With Atrial Fibrillation and ACS/PCI - Design, Rationale, and Status Presenter: Deepak L. Bhatt, C. Michael Gibson, Renato D. Lopes November 01, 2017
Presentation TCT 2017 The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation - How to Incorporate the Results in Clinical Practice Presenter: Deepak L. Bhatt, C. Michael Gibson November 01, 2017
Presentation TCT 2017 The PIONEER Trial: Rivaroxaban in Patients With ACS and Atrial Fibrillation - Are the Results Enough to Change Practice? Presenter: Deepak L. Bhatt, C. Michael Gibson November 01, 2017
Presentation TCT 2017 Shared Decision-making for PFO Closure: How to Make the FDA Requirements Work Presenter: Lee N. Benson, Megan Coylewright November 01, 2017
Presentation TCT 2017 When Bleeding Occurs on Warfarin or NOAC: Reversal Strategies Presenter: Robert A. Harrington, Kurt Huber, Michael D. Ezekowitz November 01, 2017
Presentation TCT 2017 Acute Anticoagulation Management and Bleeding Avoidance Strategies in the Chronic Atrial Fibrillation Patient Who Requires PCI Presenter: Robert A. Harrington, Kurt Huber, Christopher B. Granger November 01, 2017
Presentation TCT 2017 DECISION-CTO and EURO-CTO: Critique and Unanswered Questions Presenter: David J. Cohen, Ajay J. Kirtane, Emmanouil S. Brilakis November 01, 2017
Presentation TCT 2017 When and Which Antiplatelet Agent Should Be Dropped When Using Oral Anticoagulant Therapy? Presenter: Robert A. Harrington, Kurt Huber, Roxana Mehran November 01, 2017
Presentation TCT 2017 DECISION-CTO and EURO-CTO: Topline Findings and Practice Implications Presenter: David J. Cohen, Ajay J. Kirtane, Gerald S. Werner November 01, 2017
Presentation TCT 2017 Dosing Considerations of Oral Anticoagulant Therapy in the ACS and PCI Patient: Optimizing Efficacy While Minimizing Bleeding Presenter: Robert A. Harrington, Kurt Huber, Michelle O'Donoghue November 01, 2017
Presentation TCT 2017 Should the Type of Stent Influence DAPT Decisions in Patients Receiving OAC? Insights From WOEST, LEADERS Free, and More Presenter: Robert A. Harrington, Kurt Huber, Didier Carrié November 01, 2017
Presentation TCT 2017 Guidelines and Expert Consensus on Anticoagulation in the Atrial Fibrillation Patient With ACS or PCI: How Strong Is the Evidence? Presenter: Robert A. Harrington, Kurt Huber, Jean-François Tanguay November 01, 2017
News Conference News TCT 2017 Shortened DAPT Durations Appear Safe for Patients With ACS Implanted With DES Todd Neale November 01, 2017
Presentation TCT 2017 What Is (and Is Not) Known About DAPT Decisions in Patients on Chronic Oral Anticoagulants Presenter: Robert A. Harrington, Kurt Huber, Freek W.A. Verheugt November 01, 2017
Presentation TCT 2017 The Big Picture: Incremental Bleeding Risks in Patients Requiring Chronic Oral Anticoagulants Plus Antiplatelet Therapy Presenter: Robert A. Harrington, Kurt Huber, Renato D. Lopes November 01, 2017
Presentation TCT 2017 Case #2 Conclusion: A Symptomatic Diabetic Patient With Chronic Kidney Disease and 3-Vessel Disease How We Treated Presenter: David J. Maron, Alan C. Yeung, Vasim Farooq November 01, 2017